(Date:11/21/2009)..., WASHINGTON, Nov. 21 ...ment after the Senate voted to begin full debate o...o: http://www.newscom.com/cgi-bin/prnh/20080519/D...istoric step on the road to enacting health insura...le, senators will now have an opportunity to debat...
(Date:11/21/2009)..., NEW YORK, Nov. 21 Milvia Lopez...York City, recently filed suit, in Supreme Court, ...complaint alleges that while Ms. Lopez underwent a... ST. VINCENT,S HOSPITAL , doctors used an HIV inf...aint alleges that several hours after being discha...
(Date:11/21/2009)..., Association Discusses Key Provisions of Legis... Reform ,, ST. CHARLES, Ill., Nov. 21 /PRNewsw...entatives passing the landmark Affordable Health C...ving key health reform legislation forward, Congre...oken health care system. Today, AARP hosted an ed...
(Date:11/21/2009)... NH based medical credentialing s...its industry to form a partnerhsip with Amerinet, ...his partnership will help to transform quality car... (Vocus) November 21, 2009 -- ISG Group, L...nced a new agreement with Amerinet Inc., a leading...
(Date:11/21/2009)... HAPPYneuron,s most popular and a... iPhone and iPod Touch. , ...PPYneuron,s most popular and addictive game, Split...ch. Split Words is designed to help banish that ,t...Words iPhone brain game challenges the brain by ...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3(Date:11/20/2009)...swire/ -- ,, Reportlinker.com announces that a ...alogue. ,, Global Markets for Breast Biopsy De...164741/Global-Markets-for-Breast-Biopsy-Devices-20...p;utm_campaign=prnewswire ,, The global marke...oaded core needle market and vacuum assisted breas...
(Date:11/20/2009)...re-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX )...ef Executive Officer, and Greg Browne, Chief Finan...r Jaffray Health Care Conference in New York on We...nference session and webcast will be audio only an...ay will host a webcast of the presentation live an...
(Date:11/19/2009)...ewswire/ -- Warner Chilcott plc (Nasdaq: WCRX ) t...nced secondary offering of 20,000,000 of its ordin...share. The selling shareholders include funds aff...anking, J.P. Morgan Partners (advised by CCMP Capi...er institutional investors and members of the Comp...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 1NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 2Long Term Back Pain Not Inevitable Study Finds 59075 1Long Term Back Pain Not Inevitable Study Finds 59075 2Endovenous Laser Therapy Used for Treatment of Varicose Veins 59071 1Endovenous Laser Therapy Used for Treatment of Varicose Veins 59071 2...onference Call on Monday, April 14, at 8:30 a.m. E...m.com , CARLSBAD, Calif., April 14 Isis,Pharmace...l results from its,ongoing Phase 2 open-label exte...amilial hypercholesterolemia (FH). In FH patients ...e safety profile of the drug,continues to be encou...
...3 Researchers from the,Barbara Ann Karmanos Cance...owing that adding curcumin or resveratrol to conve...ing the growth of chemo-resistant colon cancer,cel...merican Association,for Cancer Research (AACR) Ann...om.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITU...
Other Medicine Technology:Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells 2...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: